ALNYLAM PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALNYLAM PHARMACEUTICALS, INC. has filed 1,678 SEC EDGAR filings since 09 Jul 2002

SEC filing history

Showing 26-50 of 207 matching filings.

Per page
25
Current page
2
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
15 Feb 2024
Reporting date
15 Feb 2024
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
02 Nov 2023
Reporting date
02 Nov 2023
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
04 May 2023
Reporting date
04 May 2023
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
23 Feb 2023
Reporting date
23 Feb 2023
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
27 Oct 2022
Reporting date
27 Oct 2022
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
28 Jul 2022
Reporting date
28 Jul 2022
Next action
Verify source filing
8-K File 001-36407

ALNYLAM PHARMACEUTICALS, INC. 8-K

Filing date
28 Apr 2022
Reporting date
28 Apr 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .